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ABSTRACT 
Background 
Rare mutations in the WFS1 gene lead to Wolfram syndrome, a severe multisystem disorder 
with progressive neurodegeneration and diabetes mellitus causing life-threatening 
complications and premature death. Only a few association studies using small clinical 
samples tested the possible effects of common WFS1 gene variants on mood disorders and 
suicide, the non-clinical spectrum has not been studied yet. 
Methods 
Self-report data on Aggression, Impulsiveness, Anxiety and Depression were collected from a 
large (N=801) non-psychiatric sample. SNPs were selected to provide an adequate coverage 
of the entire WFS1 gene, as well as to include putative microRNA binding site 
polymorphisms. Molecular analysis of the assumed microRNA binding site variant was 
performed by an in vitro reporter-gene assay of the cloned 3’ UTR with coexpression of miR-
668. 
Results 
Among the 17 WFS1 SNPs, only the rs1046322, a putative microRNA (miR-668) binding site 
polymorphism showed significant association with psychological dimensions after correction 
for multiple testing: those with the homozygous form of the minor allele reported higher 
aggression on the Buss-Perry Aggression Questionnaire (p=0.0005). Functional effect of the 
same SNP was also demonstrated in a luciferase reporter system: the minor A allele showed 
lower repression compared to the major G allele, if co-expressed with miR-668. 
Conclusions 
To our knowledge, this is the first report describing a microRNA binding site polymorphism 
of the WFS1 gene and its association with human aggression based on a large, non-clinical 
sample. 
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INTRODUCTION  
Wolfram syndrome (WS) is an autosomal recessive multisystem disorder with progressive 
neurodegeneration and diabetes mellitus [Rigoli and others 2011], also known as DIDMOAD 
(diabetes insipidus, diabetes mellitus, optic atrophy and deafness). Although the clinical 
course of WS is highly variable, the prognosis is poor as patients have an impaired quality of 
life and usually die in their thirties from central respiratory failure as a result of brainstem 
atrophy [Barrett and others 1995]. Psychiatric manifestations are common in WS patients, 
including severe depression, psychosis, as well as impulsive verbal and physical aggression 
[Swift and others 1990]. 
The mutated gene, WFS1 was identified in 1998 on chromosome 4p16.1 spanning 33.4 kb 
[Inoue and others 1998]; it has eight exons but the first exon is noncoding. The WFS1 gene 
encodes a transmembrane protein (wolframin) of the endoplasmatic reticulum (ER), 
predominantly expressed in the brain and in the pancreatic β cells, but detected nearly in all 
tissues. Although the molecular function of wolframin is not fully understood to date, current 
results suggest that wolframin has a critical role in the regulation of ER stress [Fonseca and 
others 2005; Fonseca and others 2010]. ER homeostasis is based on a sensitive balance of 
protein synthesis and protein folding capacity of the ER. Accumulation of unfolded proteins 
induces ER stress, triggering the unfolded protein response (UPR). At the same time it is of 
vital importance to avoid UPR hyperactivation, which could trigger apoptotic pathways and 
lead to cell death. According to recent data, wolframin might participate in down regulation of 
ER stress and thus, in the reestablishment of ER homeostasis [Oslowski and Urano 2011]. 
Further findings pointed out another possible role of wolframin in controlling ER calcium 
homeostasis [Takei and others 2006]. A recent study demonstrated that wolframin is a 
calcium-calmodulin binding protein, and three mutations found in WS patients completely 
abolish this function [Yurimoto and others 2009]. Taken together the findings above about the 
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molecular function of wolframin, this protein is expected to have a vital role in ER 
homeostasis of excretory cells, such as the insulin producing pancreatic β cells or the neurons 
producing synaptosomes for neurotransmission. 
Studies on the WFS1 knockout mouse provided further evidence for the significant role of 
wolframin in the brain and in the pancreas. WFS1 deficient mice had a dramatic decrease in 
the mass of the pancreatic islets and a serious impairment of glucose homeostasis [Ishihara 
and others 2004]. Results from behavioral studies of the WFS1 knockout mouse suggested 
that it could be used as an animal model of mood disorder [Kato and others 2008], impaired 
behavioral stress adaptation [Luuk and others 2009] and post-traumatic stress disorder 
[Kesner and others 2009]. 
Although more than 200 different mutations causing WS have been identified (for a recent 
database see: [M. 2010]), phenotype-genotype relationships are still not clear. Similarly, little 
is known about the clinical and molecular effects of common variants. Several single 
nucleotide polymorphisms (SNPs) have been shown as possible risk factors for type 2 
diabetes mellitus, such as the rs10010131 in intron 4 and rs1046320 in the 3’ untranslated 
region (UTR) [Fawcett and others 2010]. Other studies raised the possibility of association 
between several WFS1 SNPs and neuropsychiatric disorders, such as mood disorders 
[Kawamoto and others 2004; Koido and others 2005] and impulsive suicide [Lemonde and 
others 2003; Must and others 2009]. Although the level of significance did not survive 
corrections for multiple testing in most studies, the possible link between WFS1 genetic 
variants and psychiatric disorders is strongly supported by the fact that carriers of various 
WFS1 mutations are 26-fold more likely to be hospitalized in psychiatric institutions than 
noncarriers [Swift and Swift 2000]. 
According to our best knowledge, WFS1 polymorphisms have not been studied yet in relation 
to either aggression or mood characteristics within the non-clinical spectrum. Here we present 
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an association study of WFS1 SNPs and four psychological dimensions: Aggression, 
Impulsiveness, Anxiety, and Depression, using self-report data from a large, non-psychiatric 
sample. Study of these phenotypes was based on the main psychiatric symptoms of WS 
patients (depression and aggression), as well as on the results of the few psychogenetic 
association studies related to mood disorders and impulsive suicide. In addition, we 
characterized the molecular function of rs1046322 which had a significant effect on the 
measured phenotypes. 
MATERIALS AND METHODS 
Sample 
Caucasian (Hungarian) participants of the study signed written informed consent, provided 
buccal samples and filled out questionnaires. They were recruited at different higher 
education sites on a voluntary basis. The study protocol was approved by the Scientific and 
Research Ethics Committee of the Medical Research Council (ETT TUKEB). Valid DNA and 
questionnaire data were available from 801 subjects (46.2% males and 53.8% females). Mean 
age was 21.3 years (±3.3) within the age range of 18–35 years. 
 
Phenotypic Measures 
All subjects completed a panel of self-report measures relevant to the study of Aggression, 
Impulsiveness, Anxiety and Depression. The Buss-Perry Aggression Questionnaire [Buss and 
Perry 1992] includes 29 items, rated from 1 (extremely uncharacteristic of me) to 5 
(extremely characteristic of me). The aggression construct was measured with items loading 
on four distinct factors: Verbal Aggression (5 items), Anger (7 items), Hostility (8 items) and 
Physical Aggression (9 items). The total score for Aggression was the sum of ratings for all 
the items, thus possible total scores range from 29 to 145. The 11
th
 version of the Barratt 
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Impulsiveness Scale was designed to assess general impulsiveness using 30 items scored from 
1–4 (BIS-11; [Patton and others 1995]). In the present study the total score for Impulsiveness 
was used, with values ranging from 30–120. The English version of the questionnaires 
measuring aggression and impulsiveness were translated using the ‘forward-backward’ 
procedure and were pilot tested prior to the present study to enhance translation clarity and 
applicability. Anxiety and depression was measured by the Hungarian version of the Hospital 
Anxiety and Depression Scale (HADS; [Muszbek and others 2006]). Items are scored from 0–
3 based on the selected response category, possible total scores for both anxiety (7 items) and 
depression (7 items) range from 0 to 21. 
To assess the internal consistency, Cronbach alpha values were calculated for each phenotype 
construct in the present sample, and were found satisfactory (Aggression Total Score: 0.90; 
Impulsiveness Total Score: 0.82; Anxiety Scale: 0.77; Depression Scale: 0.74). Internal 
consistency measures of the four aggression factors were also sufficient (Verbal Aggression: 
0.64; Anger: 0.84; Hostility: 0.80; Physical Aggression: 0.84). 
 
Marker Selection 
Common (higher than 5% minor allele frequency) polymorphic loci were selected from 
dbSNP database using HapMap information about linkage disequilibrium to provide adequate 
coverage of the entire WFS1 gene. LD blocks were defined by the “Four Gamete Rule” using 
Haplowiev 4.2. At least two SNPs have been investigated in each block taking the 
chromosomal localization also into consideration. Our goal was to generate a balanced 
“physical coverage” so that no segments longer than 6 kb remained uncovered. Priority was 
given to those SNPs which were referred in various association studies in connection with 
diabetes mellitus and psychiatric disorders. SNPs, theoretically influencing microRNA 
binding, were searched in the polymiRTS and Patrocles databases. 
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DNA and genotyping 
Genomic DNA was extracted from buccal swabs by Gentra purification kit (Minneapolis, US) 
according to manufacturer’s instructions and quantified by fluorometry employing an 
intercalation assay (AccuBlue Broad Range dsDNA Quantitation Kit, Biotium, Hayward, 
CA). Typical DNA concentration was about 50 ng/µl (range: 15–200 ng/µl). 
Genotyping was performed by an Open Array
®
 real-time PCR platform of Applied 
Biosystems (Foster City, CA) based on the 5’ nuclease assay with pre-designed and validated 
primers and allele-specific, fluorescent (TaqMan) probes immobilized to a solid surface. 
Approximately 100 ng (range: 30–150 ng) DNA was applied for each SNP subarray. The 
master mix, containing each dNTP and the AmpliTaq Gold DNA-polymerase, was supplied 
by the manufacturer. The thermocycle was carried out according to the manufacturer’s 
instruction. Allele specific FAM and VIC fluorescent intensities were measured after the PCR 
amplification, genotypes were called using the TaqMan Genotyper v1.2 software. Call rates 
for SNPs on the OpenArray system was 88.87% in average (range: 69.37–96.00%). For 
quality control, three SNPs (rs9457, rs1046320 and rs1046322) were genotyped additionally 
on a conventional 96 well plate system with the commercially available TaqMan assay kits on 
a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA). Re-genotyping 
proved the reliability of the high-throughput OpenArray platform, as 99.1% agreement was 
observed comparing the two approaches, moreover increased the call rate of genotypes at 
these 3 loci. The genotype and allele frequencies obtained as a combination of data 
determined by the two genotyping platforms for the 801 individuals with valid data of 
questionnaires were used for association analysis between genotypes and phenotypic 
measures. Genotype frequency data for each SNP are given in Supplementary Table 1, minor 
allele frequencies (MAF) are shown in Table 1. The measured genotype frequencies 
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corresponded to the Hardy-Weinberg equilibrium for all SNPs (for p values see: 
Supplementary Table 1). Call rates for each SNP were calculated as the sum of the genotypes 
given in Supplementary Table 1 divided by the total number of participants with valid 
phenotypic data (801). 
 
Luciferase constructs of the WFS1 3’ UTR 
The entire 3’ UTR region of the human WFS1 gene was amplified by PCR of a sample with 
known rs1046322 (GG) genotype using the 5’ TCG GCG GAG CTC GGA TGG TCC GCC 
ACG AGG AGC 3’ forward and 5’ AAA GGA AAG CTT GCG CTG CAG GTT CCA CCA 
GAG G 3’ reverse primers. Bold letters indicate the Sac I and Hind III recognition sites in the 
forward and reverse primer, respectively. PCR product was purified and cloned between the 
Sac I and Hind III sites downstream to the firefly luciferase gene in pMIR-Report vector 
(Ambion) by standard protocols (pMIR-G). Construct with WFS1 3’ UTR possessing the 
rs1046322 A allele (designated pMIR-A) was generated by quick change site directed 
mutagenesis of the cloned pMIR-G, both constructs were confirmed by direct sequencing. A 
control pMIR construct (pMIR-c) was also created by cloning a DNA-fragment with identical 
length, however without the binding site of miR-668 downstream to the luciferase gene. 
 
Cell transfection and luciferase assay 
The Human Embryonic Kidney 293 (HEK293) cell line was cultured in DMEM medium 
(Invitrogen–Gibco), supplemented with 10% bovine fetal serum (Lonza) at 37 °C in an 
atmosphere of 5% CO2. HEK293 cells were transferred into 24-well plate and incubated for 
24 h before transfection. Subsequently, 0.05 µg of the luciferase reporter construct were 
cotransfected with 0.2 µg β-galactosidase vector (Ambion), and 5 pmol miR-668 using 
Lipofectamine
TM
 2000 (Invitrogen). Cells were collected 48 hours after transfection and 
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extracted by three consecutive freeze-thaw cycles followed by a centrifugation. Supernatants 
were used for luciferase assay. Luminescence for luciferase as well as optical density for β-
galactosidase were measured by Varioskan Flash Multimode Reader, luciferase activity data 
were normalized by β-galactosidase activities. All experiments were carried out in triplicates. 
Statistical analysis of normalized reporter data was performed using one-way ANOVA 
followed by Tukey-Kramer test (GraphPad InStat 3.05). 
 
Statistical Analysis 
Statistical analyses were carried out using SPSS 19.0 for Windows. Allele and genotype 
frequency distributions were tested by chi-square analyses. Independent-Samples t-test was 
applied for assessment of gender differences on self-report scales; their correlation with age 
was also calculated. Genetic associations were tested by one way analyses of covariance 
(ANCOVA) assuming a bi-allelic inheritance model and the recessivity of the minor allele. 
Sex and age were used as covariates, since both were possible confounds. Significant 
(p<0.001) gender differences were found in aggression and anxiety (males exposed higher 
aggression and lower anxiety scores). Impulsiveness and depression scores showed no 
significant sex differences. A significant weak negative correlation was found between age 
and aggression r=−0.073 (p=0.04). Other measured scales did not correlate with age. In 
association analyses nominal level of significance was corrected to p<0.0007 based on the 
Bonferroni correction for multiple testing: p=0.05 was divided by 68, the number of analyses 
performed (4 phenotypes × 17 SNPs). Lewontin’s D’ as well as R
2
 values of linkage 
disequilibrium were determined using HaploView 4.2. [Barrett and others 2005]. 
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RESULTS 
Higher aggression in AA homozygotes of WFS1 rs1046322 
Table 1 summarizes the most important information for the 17 studied WFS1 SNPs. The 
average distance between the selected SNPs was 1764 bp. Most of them are intronic, but three 
SNPs in the longest (8
th
) exon and three SNPs in the 3’ UTR region were also investigated. 
The minor allele frequency (MAF) was calculated from the genotype distribution of each 
polymorphism (see Supplementary Table 1). As our aim was to study common allelic 
variants, we selected SNPs with MAF ≥ 0.05. 
Figure 1 shows the pairwise linkage disequilibrium (LD) estimates between the studied SNPs 
of the WFS1 gene region. R
2
 (Figure 1A) as well as D’ values (Figure 1B) were assessed, the 
most apparent differences between the two measures could be observed regarding rs28716718 
and rs1801208 polymorphisms. R
2
 valu s suggested practically no LD between these two 
SNPs and the other sites, whereas D’ showed a high level of LD in this region. This finding 
can be demonstrated in that special form of LD, which can be characterized by the lack of 
exactly one haplotype, i.e. one allele is freely combined with both alleles of the adjacent site, 
however the other allele is always present together with one of the two variants of the 
neighboring polymorphism. The LD structure of WFS1 gene could be characterized by two 
(D’, block definition according to confidence intervals) or three (R
2
, block definition 
according to Four Gamete Rule) haploblocks as labeled in Figure 1. All SNPs were used for 
the subsequent association analysis. 
Individual scores for aggression, impulsiveness, anxiety, and depression were derived from 
self-report questionnaire data. Mean values are listed for all three genotypes in Table 2. Based 
on the applied recessive model of the minor allele we compared mean values of minor 
homozygotes (mm) to those carrying the major allele (MM and Mm) for each polymorphism. 
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Results of these one-way ANCOVAs are depicted in Table 2, sex and age were used as 
covariates. 
The WFS1 rs1046322 showed significant association with Aggression [F(1,797)=12.241, 
p=0.0005, η
2
=0.015, power=0.938], Impulsiveness [F(1,791)=6.362, p=0.012, η
2
=0.008, 
power=0.712], Anxiety [F(1,797)=7.801, p=0.005, η
2
=0.010, power=0.797] and Depression 
[F(1,797)=5.074, p=0.025, η
2
=0.006, power=0.614]. These scales are highly related, 
correlation values reported below are all positive with a p value lower than 0.0001 Aggression 
showed a strong correlation with Impulsiveness (r=0.43) and Anxiety (r=0.41) and a 
somewhat weaker correlation with Depression (r=0.37). Impulsiveness was related to both 
Anxiety (r=0.27) and Depression (r=0.25). Correlation was the highest between Anxiety and 
Depression (r=0.57). Participants with the homozygous form of the rs1046322 minor allele 
(mm) reported significantly higher aggression, they were also more impulsive, more anxious 
and more depressed than those with genotypes including the major allele (see total scores for 
each self-report scale in Table 2). 
Other WFS1 SNPs did not show significant association with Aggression, Impulsiveness or 
Anxiety scores. Depression was associated with two other WFS1 SNPs from the 1
st
 
haploblock: rs10002743 [F(1,678)=6.777, p=0.009, η
2
=0.01, power=0.739] and rs6824720 
[F(1,673)=6.789, p=0.009, η
2
=0.01, power=0.740]. These SNPs are in strong linkage 
disequilibrium with each other, but not with the WFS1 rs1046322 polymorphism (see Figure 
1). 
Due to performing multiple comparisons, the accepted level of significance was corrected to 
rule out false positive results. From the nominally significant associations (labeled by bold in 
Table 2) only effect of the WFS1 rs1046322 on Aggression remained significant after the 
stringent Bonferroni correction (corrected p value was 0.0007). As highlighted in Table 2, 
participants with the AA genotype (homozygous for the minor allele) showed the highest 
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aggression (mean total score = 85.8), whereas subjects with the AG and GG genotypes scored 
notably lower (their mean total score was 66.3 and 66.4, respectively). It is important to note 
that only 9 participants out of 801 carried this rare variant (see Supplementary Table 1 for 
genotype distribution). To test consistency of this genetic effect we calculated mean 
aggression raw scores for each factor, and compared the average Verbal Aggression, Anger, 
Hostility and Physical Aggression values for the WFS1 rs1046322 genotypes. Figure 2 shows 
that aggression level of those with the AA variant are notably higher in all four dimensions as 
compared to aggression level of carriers of the major allele (AG and GG genotypes). This 
result indicates that the applied genetic model fits data from the different dimensions of 
aggression as well as the main construct. 
 
Molecular-functional study of rs1046322 
The rs1046322 SNP which had a significant effect on aggression, impulsiveness, and 
depression is located in the 3’ UTR of the WFS1 gene (see Table 1) and does not fall into any 
of the identified haploblocks (see Figure 1). This SNP was selected as a putative microRNA 
binding site polymorphism (miRSNP). According to the PolymiRTS database, the minor 
allele (A) generates a mismatch in the target site of the seed region of miR-668. To explore 
whether the rs1046322 polymorphism alters the miR-668 binding efficiency under 
experimental conditions, a firefly luciferase reporter vector containing the 3’ UTR region of 
the WFS1 gene (pMIR-G) was constructed, and its minor allelic variant was generated by site 
directed mutagenesis (pMIR-A). The control construct (pMIR-c) possessed an independent 
sequence with the same length, lacking any complementary region with miR-668. HEK293 
cells were cotransfected with miR-668 and with pMIR-G, pMIR-A or pMIR-c, respectively, 
transfection efficiency was determined by β-galactosidase reporter vector. The average values 
of the relative luciferase activities are shown in Figure 3. Expression level was decreased by 
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miR-668 in the presence of both allelic variants (pMIR-A and pMIR-G) compared to the 
control (pMIR-c). The wild type 3’ UTR variant (pMIR-G) inhibited the luciferase expression 
upto 28% of the control, while pMIR-A resulted only in a 47% silencing effect. ANOVA 
followed by post hoc analysis showed a statistically significant (p < 0.05) difference between 
the luciferase reporter activity of the pMIR-G and pMIR-A constructs (ANOVA p = 0.0005). 
Co-transfection of a control miRNA lacking a binding site in the WFS1 3’ UTR did not result 
in the decrease of relative luciferase activity. 
 
DISCUSSION 
Loss of function mutation of WFS1 gene leads to serious neurodegeneration and early death, 
suggesting a central role of this protein in the function of the nervous system. Studies on the 
common WFS1 polymorphisms to date focused primarily on major depression, bipolar 
depression and suicidality. Kawamoto and colleagues [Kawamoto and others 2004] examined 
association of mood disorders and certain haplotypes of WFS1. The p.H611R (rs734312) 
missense exon polymorphism of the WFS1 gene has been linked to mood disorders [Koido 
and others 2005] in different populations [Zalsman and others 2009]. Suicidal behavior is 
often a symptom of an underlying psychological disorder, especially mood disorders. 
Sequeira and colleagues [Sequeira and others 2003] found higher frequency of the WFS1 
611R/611R genotype in a small sample of completed suicide victims in the general 
population. This result, however, has not been confirmed by Zalsman and coworkers 
[Zalsman and others 2009]. A recent study of 4p chromosomal region identified various risk 
factors of completed suicide in males in several genes including the p.H611R (rs734312) of 
WFS1, but these results were not significant after the stringent corrections for multiple 
testing. Interestingly, the risk allele was A in this recent study in opposite to the results of 
Page 13 of 28
John Wiley & Sons, Inc.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Kovacs-Nagy et al. WFS1 and aggression 
14 
Sequeira et al. [Sequeira and others 2003] where the G allele emerged as the risk factor of 
completed suicide. 
Based on the above only a handful of association studies investigated the effect of certain 
WFS1 gene variants on mood disorders and suicide using clinical samples. Results are rather 
contradictory, which may be a consequence of the small sample size. It is also possible that 
the most widely investigated WFS1 p.H611R (rs734312) polymorphism is only a marker, 
being in linkage disequilibrium with another functional polymorphism of the WFS1 gene, 
such as the microRNA binding site polymorphism (miRSNP) studied here, which has not 
been assessed previously. 
Recent investigations suggested that miRNAs are important regulators of protein synthesis 
[Bartel 2004]. There is a short (6–8 basepairs) complementary region between the miRNA 
binding site of the target mRNA and the “seed sequence” of miRNA. A SNP, which 
influences the microRNA binding (miRSNP), probably has a significant effect on the rate of 
target protein synthesis. Therefore, miRSNPs represent a novel class of functional 
polymorphisms, playing an important role in the genetics and pharmacogenetics of complex 
diseases [Bertino and others 2007]. For example, the miRSNP of dihydrofolate reductase gene 
was associated with resistance to methotrexate, an anticancer drug [Mishra and others 2007]. 
There are also a few studies emphasizing the role of the miRSNPs in neuropsychiatric 
disorders, such as Parkinson’s disease and Tourette syndrome [Sethupathy and Collins 2008]. 
The rs686 of the DRD1gene, previously associated with nicotine dependence, was shown to 
function as miRSNP [Huang and Li 2009]. Recently, it was demonstrated [Jensen and others 
2009] that the rs13212041 in the serotonin receptor 1B gene, which was associated to 
aggression among college students, disrupts a sequence critical for a miR-96 binding. An 
additional evidence for this miRSNP was also provided by the same group showing an 
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association of a haplotype involving rs13212041 with self-reported anger and hostility in 
young men [Conner and others 2010]. 
Searching in various databases we found two putative miRSNPs (rs9457, rs1046322) in the 
WFS1 gene. According to our best knowledge, these common variants have not been tested 
previously in psychogenetic or diabetes mellitus related association studies. We found that 
one of these putative miRSNPs, the rs1046322 was associated with aggression and related 
dimensions. Our in silico studies indicated that the A allele weakens the binding of miR-668. 
We also provided experimental evidence about the effect of this SNP on miR-668 binding: 
coexpressing the cloned WFS1 3’ UTR possessing A or G alleles with miR-668 resulted in 
changes of luciferase reporter activity. These results suggest that the rs1046322 SNP has an 
important molecular function in the regulation of WFS1 gene expression and should be 
included into further association studies of the WFS1 gene. We hypothesize that the negative 
regulation of wolframin protein synthesis is less pronounced in the presence of the minor 
allele of the rs1046322 leading to an overexpression of wolframin and an imbalance in ER 
stress regulation. Limitation of our hypotheses is the lack of in vitro or in vivo studies that 
would support the role of miR-668 in the regulation of the wolframin protein synthesis. 
Studies to date did not investigate association of WFS1 polymorphisms with impulsivity, 
aggression or mood characteristics within the non-clinical spectrum. According to the 
psychiatric literature, these dimensions are interrelated [Apter and others 1990]. Results of the 
correlation analysis from our present study also showed that Aggression was in a strong 
correlation with Impulsiveness (r=0.43, p<0.0001)) and Anxiety (r=0.41, p<0.0001), although 
they were assessed with different tools and in populations of different type and size. 
The aim of the present study was to detect possible genetic effects of a comprehensive set of 
WFS1 polymorphisms, involving putative miRSNPs, on psychological dimensions using self-
report data from 801 non-related, healthy Caucasians. Our set of 17 WFS1 SNPs included the 
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p.H611R (rs734312) polymorphism that was previously associated with mood disorders, 
however, we did not find any association with impulsivity, aggression or mood characteristics 
in our large, non-clinical sample. Results from our association analyses revealed a novel risk 
factor of the impulsive-aggressive tendencies within the non-clinical range: The WFS1 
rs1046322 polymorphism, which was identified here as a miRSNP, showed significant 
association with all the measured scales: Aggression (p=0.0005), Impulsiveness (p=0.0119), 
Anxiety (p=0.0053) and Depression (p=0.0246). Subjects homozygous for the minor allele 
(AA) showed higher aggression, higher impulsivity, higher anxiety and higher depression as 
compared to those without the rare risk genotype. It is important to note, that when correcting 
the level of significance to rule out false positive results of multiple comparisons only the 
effect of rs1046322 on Aggression remained significant. Although application of the stringent 
Bonferroni correction is an important principle in current association studies, we would like to 
emphasize that most of our nominally significant associations emerged between the WFS1 
rs1046322 and the other three dimensions (Impulsiveness, Anxiety and Depression) 
interrelated with Aggression suggesting a significant and complex effect of this miRSNP on 
the behavior. 
Dimensions of aggression, impulsivity, anxiety, and depression are correlated and are linked 
to certain psychopathologies, but also cause disturbances in the emotions, decision making 
and self-regulation within the non-clinical spectrum. Association studies highlight the role of 
various genetic and environmental predisposing factors in the polygenic model of these 
behaviors and acknowledge the importance of understanding interaction effects between these 
components through the study of psychiatric patients as well as the non-clinical population 
[Courtet and others 2011]. To our knowledge, this is the first association study of a validated 
microRNA binding site polymorphism in the WFS1 gene. This functional polymorphism was 
shown as a genetic factor of individual variations in aggression. 
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Limitation of the present study is the applied self-report method for portraying such a 
complex dimension as aggression, however, this tool was sufficient for large-scale 
assessment. We tested 801 subjects, but there were only 9 subjects (5 males and 4 females) 
homozygous with the risk allele (AA) of the microRNA binding site polymorphism 
(rs1046322) of the WFS1 gene, although the call rate for this SNP was 100% as a result of 
double genotyping (see: Supplementary Table 1). Recessivity of the risk allele might be 
explained by the identified molecular effect of the rs1046322 minor A allele. If microRNA 
serves as a fine tuning of gene expression, the ER balance could be disturbed only in the 
presence of both risk alleles. These subjects showed substantially higher levels of aggression 
(mean value was 86(±22) as compared to the overall aggression average: 67(±16). Due to the 
small number of subjects with the risk genotype replication of these findings would be 
important in an independent non-clinical population. Investigation of this novel functional 
polymorphism in clinical samples with mood disorders and suicide would also be essential. 
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LEGENDS TO THE FIGURES 
Figure 1. Linkage disequilibrium plots of the WFS1 SNPs. 
A: R
2
 (%) measure of linkage disequilibrium between any pair of SNPs, as determined by 
HaploView, version 4.2. The gray-scale spectrum indicates pairwise R
2
 values ranging from 
black (R
2
=1) to white (R
2
=0). B: Pairwise LD values expressed by D’ (HaploView v4.2). Red 
squares indicate 100% LD. 
 
Figure 2. The effect of the rs1046322 WFS1 SNP in the Buss-Perry Aggression Scale. 
Mean raw score values with standard errors of mean for the 4 aggression factors are shown. 
 
Figure 3. The silencing effect of the rs1046322 
HEK293 cells were cotransfected with miR-668 and with pMIR-G, pMIR-A or pMIR-c 
construct, respectively. Relative luciferase activities (mean ± SD) from three independent 
experiments are shown. ANOVA showed a statistically significant difference between the 
luciferase activity of pMIR-A and pMIR-G constructs (p = 0.0005). 
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Linkage disequilibrium plots of the WFS1 SNPs.  
A: R2 (%) measure of linkage disequilibrium between any pair of SNPs, as determined by HaploView, version 
4.2. The gray-scale spectrum indicates pairwise R2 values ranging from black (R2=1) to white (R2=0). B: 
Pairwise LD values expressed by D’ (HaploView v4.2). Red squares indicate 100% linkage.  
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The effect of the rs1046322 WFS1 SNP in the Buss-Perry Aggression Scale.  
Mean raw score values with standard errors of mean for the 4 agression factors are shown.  
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HEK293 cells were cotransfected with miR-668 and with pMIR-G, pMIR-A or pMIR-c construct, respectively. 
Relative luciferase activities (mean ± SD) from three independent experiments are shown. ANOVA showed a 
statistically significant difference between the luciferase activity of pMIR-A and pMIR-G constructs (p = 
0.0005).  
260x196mm (96 x 96 DPI)  
 
 
Page 26 of 28
John Wiley & Sons, Inc.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Kovacs-Nagy et al. WFS1 and aggression 
 
Table 1. Main characteristics of the selected WFS1 SNPs. 
 
dbSNP 
number 
Genomic 
position 
Inter-SNP 
distance (bp) Type   MAF* 
rs10002743 6276581    intron 2  0.191 
rs6824720 6278647  2066  intron 2  0.159 
rs752854 6281961  3314  intron 3  0.310 
rs4689393 6287241  5280  intron 3  0.435 
rs10010131 6292915  5674  intron 4  0.391 
rs13147655 6293474  559  intron 6  0.384 
rs4467645 6294305  831  intron 7  0.394 
rs13128674 6294517  212  intron 7  0.409 
rs6446482 6295693  1176  intron 7  0.398 
rs4689395 6295985  292  intron 7  0.359 
rs28716718 6301910  5925  intron 8  0.053 
rs1801208 6302889  979  exon 8 (p.R456H)  0.050 
rs734312 6303354  465  exon 8 (p.H611R)  0.462 
rs1046316 6304087  733     exon 8 (p.S855S)  0.341 
rs1046320 6304344  257  3’ UTR  0.403 
rs1046322 6304448  104  3’ UTR  0.099 
rs9457 6304799   351   3’ UTR   0.433 
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Table 2. Association of WFS1 genotypes with self-report measures 
Mean values of the total score are presented for each genotype 
*significant with Bonferroni correction 
 
    AGGRESSION (BUSS-PERRY)   IMPULSIVITY (BARRAT)   ANXIETY (HADS)   DEPRESSION (HADS) 
WFS1 SNP   (MM) (Mm) (mm)  p   (MM) (Mm) (mm)  p   (MM) (Mm) (mm)  p   (MM) (Mm) (mm)  p 
rs10002743  66.2 68.1 66.1 0.8711  58.3 59.8 61.1 0.2133  5.7 5.7 6.5 0.3196  2.5 2.7 3.8 0.0094 
rs6824720  66.4 67.1 64.1 0.5821  58.8 59.7 61.6 0.2611  5.7 5.6 6.7 0.3235  2.5 2.7 4.1 0.0094 
rs752854  67.5 66.5 66.8 0.8727  58.6 58.8 57.9 0.5744  5.7 5.5 5.3 0.6456  2.7 2.6 2.6 0.9468 
rs4689393  66.2 67.5 66.6 0.9975  58.0 59.4 59.4 0.5180  5.5 5.7 5.6 0.9226  2.4 2.7 2.7 0.6312 
rs10010131  66.8 66.2 64.8 0.3542  58.1 59.8 58.5 0.6086  5.8 5.9 5.4 0.2070  2.6 2.5 2.7 0.7347 
rs13147655  66.6 67.4 66.1 0.7131  57.9 59.4 58.7 0.9993  5.7 5.7 5.5 0.4438  2.6 2.7 2.8 0.7246 
rs4467645  66.5 67.2 66.2 0.7985  58.3 59.4 58.9 0.9656  5.6 5.8 5.6 0.6563  2.6 2.6 2.7 0.6657 
rs13128674  66.9 67.4 67.2 0.8759  58.1 58.8 59.0 0.6345  5.5 5.6 5.6 0.8510  2.7 2.7 2.9 0.6256 
rs6446482  66.3 67.3 67.0 0.8364  57.8 59.4 59.1 0.6555  5.5 5.7 5.6 0.8530  2.5 2.6 2.8 0.4933 
rs4689395  66.6 66.6 67.0 0.8654  58.6 59.2 59.0 0.9261  5.7 5.7 5.5 0.7063  2.6 2.6 2.7 0.9011 
rs28716718  66.5 66.8 72.2 0.4960  58.8 59.9 57.0 0.6773  5.6 5.7 7.0 0.5337  2.6 2.8 3.8 0.3753 
rs1801208  66.6 68.5 72.5 0.5980  59.0 58.0 59.0 0.938  5.6 5.9 7.8 0.1544  2.6 2.7 2.8 0.9045 
rs734312  66.0 67.4 66.5 0.9215  58.7 58.8 58.9 0.8644  5.6 5.7 5.7 0.9185  2.6 2.6 2.8 0.4407 
rs1046316  67.3 67.5 66.4 0.8790  58.8 58.2 59.7 0.3845  5.5 5.6 5.6 0.9628  2.7 2.7 2.8 0.8360 
rs1046320  66.9 66.5 66.3 0.8793  58.1 59.3 58.4 0.6323  5.7 5.8 5.3 0.1697  2.7 2.7 2.5 0.5612 
rs1046322  66.4 66.3 85.8 0.0005*  58.6 59.1 66.9 0.0119  5.6 5.8 8.8 0.0053  2.6 2.7 4.7 0.0246 
rs9457   66.3 67.3 65.8 0.5462   57.8 59.2 58.2 0.6403   5.4 5.8 5.5 0.6373   2.6 2.8 2.7 0.9249 
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